Product Description

🔹 Product Overview
Arsenam 10 mg Injection contains Arsenic Trioxide 10 mg/10 mL, an antineoplastic medicine used primarily in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. It is a cytotoxic medicine that must be administered under specialist oncology supervision.

🔹 Composition
Active Ingredient: Arsenic Trioxide
Strength: 10 mg/10 mL
Concentration: 1 mg/mL
Dosage Form: Injection
Route: Intravenous infusion
Therapeutic Class: Antineoplastic / Anticancer agent

🔹 Uses and Indications
Arsenam 10 mg may be used under an oncologist's direction for:
Acute promyelocytic leukemia (APL)
Newly diagnosed APL in appropriate treatment protocols
Relapsed or refractory APL in selected patients
Other hematologic malignancies only when specifically indicated by a specialist

The exact treatment regimen depends on the patient's disease status and whether arsenic trioxide is being used alone or with other medicines.

🔹 How It Works
Arsenic trioxide acts on abnormal promyelocytes by promoting cell differentiation and programmed cell death (apoptosis). This helps reduce the population of malignant leukemia cells.

🔹 Key Benefits
Provides arsenic-trioxide-based treatment for appropriate APL patients.
Targets malignant promyelocytic cells through differentiation and apoptosis.
Available as a 10 mg/10 mL intravenous formulation.
Can be incorporated into established APL treatment protocols under specialist supervision.

🔹 Dosage And Administration
The dose and treatment schedule are determined by the treating hematologist/oncologist according to the patient's body weight, disease status, treatment protocol, blood counts, electrolyte levels and other clinical factors.
Arsenam is administered intravenously by qualified healthcare professionals. It should never be self-administered.

🔹 Possible Side Effects
Potential adverse effects include:
Nausea and vomiting
Fatigue
Headache
Fever
Diarrhea
Abdominal discomfort
Rash
Increased heart rate
Changes in blood glucose
Electrolyte abnormalities
More serious complications can occur, including QT-interval prolongation/serious cardiac arrhythmias, differentiation syndrome, hepatotoxicity and significant electrolyte disturbances. Close monitoring is therefore essential.

🔹 Precautions And Monitoring
Treatment should be conducted under experienced hematology/oncology supervision.
ECG monitoring may be required because arsenic trioxide can prolong the QT interval.
Potassium and magnesium levels should be appropriately monitored and corrected.
Blood counts, liver function and other laboratory parameters may require regular monitoring.
Inform the doctor about existing heart disease, liver problems or medicines that can affect cardiac rhythm.
Seek urgent medical attention for shortness of breath, unexplained weight gain, swelling, chest pain, fainting, palpitations or severe weakness.
Keep the medicine out of reach of children.